期刊文献+

恶性黑色素瘤38例临床分析 被引量:4

Clinical analysis of 38 patients with malignant melanoma
下载PDF
导出
摘要 回顾分析了16年间收治的38例恶性黑色素瘤的临床资料。结果1年生存率54.1%(20/37),3年生存率28.1%(9/32),5年生存率24%(6/25),7年以上生存率16.7%(3/18)。初步研究结果提示,恶性黑色素瘤应早期发现,早期诊断,早期切除,并配合化疗、放疗和免疫综合性治疗,可有效提高患者的治愈率及生存率。 The clinical data of 38 cases of malignant melanoma during 16 years were collected and analysed ret rospectively. The results showed that 1-year survival was 54. 1%(20/37), 3-year survival 28. 1%(9/32), 5-year survival 24.0(6/25) and 7-year or over survival 16.7%(3/18). The key of malignant melanoma treatment was early di agnosis, early operation combined with chemotherapy, radiotherapy and immune therapy.
出处 《肿瘤防治杂志》 2005年第16期1265-1266,共2页 China Journal of Cancer Prevention and Treatment
关键词 黑色素瘤/外科手术 黑色素瘤/药物疗法 回顾性研究 melanoma/surgical procedures, operative melanoma/drug therapy retrospective studies
  • 相关文献

参考文献5

二级参考文献18

  • 1[1]Karnell R, Kagedal B, Lindholm C, et al. The value of cysteinyldopa in the follow-up of disseminated malignant melanoma. Melanoma-Res.2000, 10(4):363 - 9
  • 2[2]Pu LL, Cruse CW, Wells KE, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. PlastReconstr-Surg. 1999,104(4):964 - 9
  • 3[3]Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin:Clinical experience in malignant melanoma patients. Clin-CancerRes.2000,6(3) :863 - 7
  • 4[4]Enk AH, Nashan D, Rubben A, et al. High dose inhalation interleukin-2therapy for lung metastases in patients with malignant melanoma. Cancer,2000,88(9): 2042 - 6
  • 5[5]Savas B,Arslan G,Gelen T,et al. Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy. AnticancerRes,1999,19(5C): 4413 - 20
  • 6[6]Ascierto PA,Palmieri G,Parasole R,et al.3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma. Int-J-Mol-Med, 1999,3 (3): 303 - 6
  • 7[7]Grimm EA, Smid CM, Lee JJ, et al. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy. Clin-Cancer-Res, 2000,6(10): 3895 - 903
  • 8[8]McClay EF, McClay ME, Monroe L, et al. The effect of tamoxifen and cisplatin on the isease-free and overall survival of patients with high risk malignant melanoma. Br-J -Cancer, 2000,83 (1): 16 - 21
  • 9[9]Yamazaki N, Yamamoto A, Wada T, et al. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma. J-Dermatol, 1999,26 (8): 489 - 93
  • 10[10]Graham MV. Hypofractioaated radiation therapy in the modern era. Rays,1999,24(3): 400 - 5

共引文献27

同被引文献14

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部